These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2226237)

  • 1. Kemron. Low dose natural human interferon alpha for oral administration (general information and technical details).
    East Afr Med J; 1990 Jul; 67(7 Suppl 2):SS82-6. PubMed ID: 2226237
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of Kemron (low dose oral natural human interferon alpha) in the management of HIV-1 infection and acquired immune deficiency syndrome (AIDS).
    Koech DK; Obel AO
    East Afr Med J; 1990 Jul; 67(7 Suppl 2):SS64-70. PubMed ID: 2226235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotherapy with interferon in AIDS-related Kaposi's sarcoma.
    Mitsuyasu RT; Miles SA
    Oncol Nurs Forum; 1987; 14(6 Suppl):27-31. PubMed ID: 3320983
    [No Abstract]   [Full Text] [Related]  

  • 4. R-interferon alpha A and suramin sodium in the treatment of AIDS and ARC cases.
    Raise E; Gritti FM; Bonazzi L; Monti M; Grillo A; Savoia M; Gambetti M; Pulsatelli L; Casertano MG; Di Figlia C
    J Exp Pathol; 1987; 3(4):737-43. PubMed ID: 3454811
    [No Abstract]   [Full Text] [Related]  

  • 5. WHO on low-dose oral interferon-alpha for AIDS.
    Lancet; 1990 Oct; 336(8720):935. PubMed ID: 1976944
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of recurrent common warts with one low dose of intralesional natural human leukocyte interferon alpha.
    Pueyo S; Criscuolo M; Davidovich C; Zorzópulos J; Pesce A; Díaz A
    J Biol Regul Homeost Agents; 1990; 4(2):47-50. PubMed ID: 2260502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doubts over 'wonderdrug'.
    Concar D; Gershon D
    Nature; 1990 Oct; 347(6292):416. PubMed ID: 2215655
    [No Abstract]   [Full Text] [Related]  

  • 8. Exacerbation of epidemic Kaposi's sarcoma with a combination of interleukin-2 and beta-interferon: results of a phase 2 study.
    Krigel RL; Padavic-Shaller KA; Rudolph AR; Poiesz BJ; Comis RL
    J Biol Response Mod; 1989 Aug; 8(4):359-65. PubMed ID: 2666585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phase I study of human lymphoblastoid alpha-interferon on malignant tumor].
    Furue H
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):977-83. PubMed ID: 3963861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy and alpha-interferon in the treatment of Kaposi's sarcoma associated with acquired immune deficiency syndrome.
    Shepherd FA; Evans WK; Garvey B; Read SE; Klein M; Fanning MM; Coates R
    CMAJ; 1988 Oct; 139(7):635-9. PubMed ID: 2458177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic trials with HPA23, alpha-IFN and ribavirin in AIDS patients.
    Moroni M; Lazzarin A; Orlando G; Crocchiolo P; Castagna A; Verani P
    Chemioterapia; 1987 Jun; 6(2 Suppl):639-41. PubMed ID: 3509513
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral use of human alpha interferon in cats.
    Cummins JM; Tompkins MB; Olsen RG; Tompkins WA; Lewis MG
    J Biol Response Mod; 1988 Oct; 7(5):513-23. PubMed ID: 3183686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Behçet disease and exogenous interferon. A successful treatment study using recombinant alpha-A-IFN].
    Stadler R; Bratzke B; Baumann I
    Hautarzt; 1987 Feb; 38(2):97-100. PubMed ID: 3570783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose oral interferon in patient with AIDS.
    Hutchinson V; Cummins JM
    Lancet; 1987 Dec; 2(8574):1530-1. PubMed ID: 2892094
    [No Abstract]   [Full Text] [Related]  

  • 15. A phase II trial of high-dose human lymphoblastoid alpha interferon in patients with advanced renal carcinoma.
    Vugrin D; Hood L; Laszlo J
    J Biol Response Mod; 1986 Aug; 5(4):309-12. PubMed ID: 3734846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of interferons in hemato-oncology].
    Harousseau JL
    Pathol Biol (Paris); 1989 Nov; 37(9):1016-7. PubMed ID: 2608325
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II trial of lymphoblastoid interferon in metastatic malignant melanoma.
    Goldberg RM; Ayoob M; Silgals R; Ahlgren JD; Neefe JR
    Cancer Treat Rep; 1985; 69(7-8):813-6. PubMed ID: 4016791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on the antitumor activity of alpha interferon.
    Quesda JR
    Oncology (Williston Park); 1988 Mar; 2(3):49-54. PubMed ID: 3079324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in natural and recombinant interferon for herpes keratitis in two animal models.
    Sanitato JJ; Varnell ED; Kaufman HE; Raju VK
    Invest Ophthalmol Vis Sci; 1984 Jul; 25(7):874-6. PubMed ID: 6735652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic use of alpha interferon in metastasizing malignant melanoma, disseminated Kaposi sarcoma and severe Behçet disease].
    Stadler R; Bratzke B; Orfanos CE
    Hautarzt; 1987 Aug; 38(8):453-60. PubMed ID: 3654216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.